Miebo

— THERAPEUTIC CATEGORIES —
  • Dry eye

Miebo Generic Name & Formulations

General Description

Perfluorohexyloctane 100%; oph soln.

Pharmacological Class

Semifluorinated alkane.

How Supplied

Soln—5mL (w. dropper)

Manufacturer

Generic Availability

NO

Mechanism of Action

Perfluorohexyloctane forms a monolayer at the air-liquid interface of the tear film which can be expected to reduce evaporation. The exact mechanism of action in dry eye disease is not known.

Miebo Indications

Indications

Dry eye disease.

Miebo Dosage and Administration

Adult

≥18yrs: 1 drop into affected eye(s) 4 times daily. 

Children

<18yrs: not established. 

Miebo Contraindications

Not Applicable

Miebo Boxed Warnings

Not Applicable

Miebo Warnings/Precautions

Warnings/Precautions

Contact lenses: remove prior to and for ≥30mins after administration. Pregnancy. Nursing mothers. 

Miebo Pharmacokinetics

See Literature

Miebo Interactions

Not Applicable

Miebo Adverse Reactions

Adverse Reactions

Blurred vision.

Miebo Clinical Trials

See Literature

Miebo Note

Not Applicable

Miebo Patient Counseling

See Literature